Contribution Share Increases by 29%
Global Ranking Rises from 77th to 64th

Seoul Asan Medical Center announced on July 6 that it ranked first in Korea and 64th in the world in the 'Nature Index 2026 Leading Medical Research Institutions' ranking. The research contribution share, which measures research impact, increased by approximately 29% from 25.9 points last year to 33.4 points this year, achieving the highest ranking among domestic medical institutions.


Seoul Asan Hospital exterior view. Seoul Asan Hospital

Seoul Asan Hospital exterior view. Seoul Asan Hospital

View original image

The Nature Index is an indicator that assesses the research competitiveness of institutions based on papers published in high-quality academic journals. Research outcomes are compiled based on papers published in 178 leading journals, including the New England Journal of Medicine (NEJM), The Lancet, Journal of the American Medical Association (JAMA), and Nature. Rankings are determined not by the sheer number of papers, but by a contribution share metric that reflects the degree of research contribution. The share is calculated by considering the number of authors and affiliated institutions for each paper, providing an indicator of each institution's actual research contribution.


In this evaluation, which covered research achievements published between January and December 2025, Seoul Asan Medical Center recorded a contribution share of 33.4 points and 119 published papers. As a result, its global ranking rose 13 places from 77th last year to 64th this year.


Starting this year, the Nature Index revamped its evaluation system to classify research fields by individual papers rather than by journal categories. The scope of evaluation was expanded from primarily natural sciences and health sciences to also include applied sciences and social sciences, enabling more precise reflection of integrated research achievements such as medical AI and digital healthcare.


Seoul Asan Medical Center achieved the top domestic ranking based on contribution share in its first assessment under the expanded evaluation scope and advanced analysis methods. The hospital explained that the approximately 29% year-on-year increase in contribution share demonstrates the continued growth in the hospital's research influence in leading global journals.


Taewon Kim, President of Seoul Asan Medical Center, stated, "This achievement demonstrates that the research capabilities of Seoul Asan Medical Center are being recognized internationally. We will continue to strengthen our support systems to further enhance research competitiveness and foster an environment that produces world-class research outcomes."



Seoul Asan Medical Center published a total of 10 papers in the NEJM, which is regarded as the most prestigious academic journal in clinical medicine. This is the highest number among domestic medical institutions, and the hospital noted that, even compared to major hospitals worldwide, these results are highly competitive.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing